Zymeworks Net Profit Margin 2016-2022 | ZYME

Zymeworks net profit margin from 2016 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
Zymeworks Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $0.03B $-0.24B -860.71%
2021-12-31 $0.03B $-0.21B -788.89%
2021-09-30 $0.02B $-0.21B -921.74%
2021-06-30 $0.02B $-0.22B -1018.18%
2021-03-31 $0.03B $-0.20B -609.38%
2020-12-31 $0.04B $-0.18B -464.10%
2020-09-30 $0.03B $-0.22B -860.00%
2020-06-30 $0.03B $-0.17B -573.33%
2020-03-31 $0.03B $-0.16B -623.08%
2019-12-31 $0.03B $-0.15B -483.33%
2019-09-30 $0.06B $-0.06B -112.28%
2019-06-30 $0.05B $-0.05B -103.92%
2019-03-31 $0.07B $-0.03B -46.15%
2018-12-31 $0.05B $-0.04B -69.81%
2018-09-30 $0.07B $-0.01B -17.57%
2018-06-30 $0.07B $-0.01B -13.89%
2018-03-31 $0.05B $-0.02B -29.41%
2017-12-31 $0.05B $-0.01B -19.61%
2017-09-30 $0.00B $-0.05B -1800.00%
2017-06-30 $0.01B $-0.05B -1000.00%
2017-03-31 $0.01B $-0.05B -460.00%
2016-12-31 $0.01B $-0.03B -330.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.336B $0.027B
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.724B 9.84
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.093B 15.93
Biohaven Pharmaceutical Holding (BHVN) United States $9.948B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.434B 0.00
Emergent Biosolutions (EBS) United States $1.592B 6.82
Arcus Biosciences (RCUS) United States $1.327B 33.64
Myovant Sciences (MYOV) United Kingdom $0.961B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.483B 0.00
Gelesis Holdings (GLS) United States $0.357B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.117B 24.00
SQZ Biotechnologies (SQZ) United States $0.092B 0.00